文献速递神经MR

深度学习方法或可减少脑MRI钆对比剂剂量

Deep learning-based methods may minimize GBCA dosage in brain MRI.
PubMed 文献 · Eur Radiol · 2021-03-18

本研究纳入83例脑增强MRI患者,采集零剂量、低剂量(10%)和全剂量(100%)钆对比剂3D T1加权图像,用前30例训练深度学习模型从零剂量与低剂量图像合成全剂量图像,后53例测试。合成图像在48/53例(90.6%)中病灶检出与真实全剂量图像一致,但多发病灶患者中仅3/6例(50.0%)检出全部病灶。作者认为该方法是减少钆对比剂用量的可行途径,但需改进算法或剂量设计以解决小病灶强化遗漏问题。

要点

  • 合成全剂量图像与真实全剂量图像病灶检出的一致率为90.6%(48/53例)。
  • 单发强化病灶检出一致率为94.4%(34/36例),多发病灶全部检出仅50.0%(3/6例)。
  • 图像质量、SNR、病灶显示度、病灶强化的一致性分别为0.73、0.63、0.89、0.87。

核心结论

  • 所提出的深度学习方法可在不牺牲诊断信息的前提下减少脑MRI钆对比剂用量,是可行途径。
  • 多发病灶患者中观察到小病灶强化遗漏,需要改进算法或剂量设计。

研究设计与样本

  • 单中心连续纳入83例(2019年3月至2019年8月)接受脑增强MRI的患者。
  • 采集零剂量、低剂量(10%)和全剂量(100%)钆对比剂3D T1加权图像。
  • 前30例用于训练深度学习模型,从零剂量与低剂量图像对合成全剂量图像;后53例用于测试。
  • 记录强化病灶的强化模式、数量和位置,评估整体图像质量、图像信噪比(SNR)、病灶显示度和病灶强化。

关键影像表现/征象

  • 深度学习方法合成的增强MRI图像在48/53例(90.6%)中病灶检出与真实全剂量增强MRI图像准确匹配。
  • 单发强化病灶患者中,深度学习方法在34/36例(94.4%)中识别出病灶。
  • 多发病灶患者中,深度学习方法仅在3/6例(50.0%)中检出全部病灶。

诊断标准与关键数值

  • 合成图像与真实全剂量增强MRI图像在图像质量、图像SNR、病灶显示度和病灶强化方面的一致性分别为0.73、0.63、0.89和0.87。

临床应用与阅片要点

  • 作者认为该方法有潜力满足某些临床应用中的常规放射诊断需求。
  • 多发病灶患者中小病灶强化遗漏需通过改进算法或剂量设计来解决。

局限性

  • 多发病灶患者中观察到小病灶强化遗漏,需要改进算法或剂量设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the clinical performance of a deep learning (DL)-based method for brain MRI exams with reduced gadolinium-based contrast agent (GBCA) dose to provide better understanding of the readiness and limitations of this method.

METHODS: Eighty-three consecutive patients (from March 2019 to August 2019) who underwent brain contrast-enhanced (CE) MRI were included. Three 3D T1-weighted images with zero-dose, low-dose (10%), and full-dose (100%) GBCA were collected. The first 30 cases were used to train a DL model to synthesize the full-dose GBCA images from the zero-dose and low-dose image pairs. The remaining 53 cases were used for testing. The enhancement pattern, number, and location of enhancing lesions were recorded. Overall image quality, image signal noise ratio (SNR), lesion conspicuity, and lesion enhancement were assessed.

RESULTS: Lesion detection from the DL-synthesized CE-MRI image accurately matched those from the true full-dose CE-MRI images in 48 of 53 cases (90.6%). The DL method identified the lesions in 34 of 36 cases (94.4%) with a single enhanced lesion and all lesions in 3 of 6 cases (50.0%) in cases with multiple enhancing lesions. The agreement between synthesized and true full-dose CE-MRI images were 0.73, 0.63, 0.89, and 0.87 for image quality, image SNR, lesion conspicuity, and lesion enhancement, respectively.

CONCLUSIONS: The proposed DL method is a feasible way to minimize the dosage of GBCAs in brain MRI without sacrificing the diagnostic information. Missing enhancement of small lesions in patients with multiple lesions was observed, requiring improvements in algorithms or dosage design.

KEY POINTS: • This study evaluated the clinical performance of a DL-based reconstruction method for significant dose reduction in GBCA contrast-enhanced MRI exams. • The proposed DL method has the potential to satisfy the routine radiological diagnosis needs in certain clinical applications.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Luo H, Zhang T, Gong NJ, et al. Deep learning-based methods may minimize GBCA dosage in brain MRI. Eur Radiol. 2021. PMID: 33735394. doi:10.1007/s00330-021-07848-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。